U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156591) titled 'Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention' on Aug. 28.
Brief Summary: A prospective, single-center, observational study to compare the risk of gastric retention between the exposure group (with neuropathy) and non-exposure group (without neuropathy) in diabetic patients receiving uninterrupted semaglutide therapy
Study Start Date: Sept. 15
Study Type: OBSERVATIONAL
Condition:
Gastric Retention
Intervention:
PROCEDURE: Esophagogastroduodenoscopy
Assess the gastric retention during esophagogastroduodenoscopy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Fudan University
Information provided ...